---
$id: https://graph.org.ai/products/commodity/51111628
$type: Product
source: UNSPSC
code: "51111628"
title: "Carmofur"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carmofur

**UNSPSC Code**: 51111628
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C11H16FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HA82M3RAB2, chemically known as 2,4-dioxo-5-fluoro-n-hexyl-3,4-dihydro-1(2h)-pyrimidinecarboxamidme but generally known as carmofur, which bears US NIH Compound Identifier 2577. European Medicines Agency schedules Carmofur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06130MIG. The term CARMOFUR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules carmofur in its Anatomical Therapeutic Chemical (ATC) Classification. CARMOFUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carmofur under HS 29335995 and SITC 51576. As of Q4 2014, CARMOFUR remains the US FDA Preferred Term for this commodity. Carmofur bears US NLM identifiers UMLS ID C0044401 and NCI Concept Code C955. SMILES: CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F.

